ADVIA CENTAUR SYPHILIS (SYPH) - COFEPRIS Registration 1771R2019 SSA
Access comprehensive regulatory information for ADVIA CENTAUR SYPHILIS (SYPH) (ADVIA CENTAUR SYPHILIS (SYPH)) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 1771R2019 SSA and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS, S. DE R.L. DE C.V.. The device was registered on August 28, 2019.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.
EL ENSAYO ADVIA CENTAUR SYPHILIS (SYPH) ES UN INMUNOENSAYO DIAGNÓSTICO IN VITRO PARA LA DETERMINACIÓN CUALITATIVA DE ANTICUERPOS FRENTE AL TREPONEMA PALLIDUM COMO AYUDA EN EL DIAGNÓSTICO DE LA SÍFILIS. EL CONTROL DE CALIDAD ADVIA CENTAUR (SYPH) QC ES PAR
THE ADVIA CENTAUR SYPHILIS ASSAY (SYPH) IS AN IN VITRO DIAGNOSTIC IMMUNOASSAY FOR THE QUALITATIVE DETERMINATION OF ANTIBODIES AGAINST TREPONEMA PALLIDUM AS AN AID IN THE DIAGNOSIS OF SYPHILIS. THE ADVIA CENTAUR (SYPH) QC QUALITY CONTROL IS EVEN